A public listing would bring liquidity and transparency. The fact we can't easily discern how far behind we are in the Human Trials, and when we can expect to see the results should show why some investors would be happier if Qbiotics was public.
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
